Beth Devine

Professor Emeritus, The CHOICE Institute. Member: Institute for Public Health Genetics; Plein Center for Aging.

Center for Pharmacy Practice Transformation, CHOICE Faculty, Department of Pharmacy, Pharmacy Faculty, Plein Center for Aging Faculty, School Faculty

Telephone: (425) 891-8074

Email: bdevine@uw.edu

Office Location: H-375-D Box 357630 1959 NE Pacific St Seattle ,WA 98195-7630

Website: Beth Devine Website

Expertise:

Causal inference, Clinical Informatics, Comparative Effectiveness Research, Economic Evaluation, Evidence Synthesis (network meta-analysis), Health Economics, Health Outcomes, Health Services Research, Health Technology Assessment, Patient-centered Outcomes Research, Pharmacogenomics, Preference Elicitation, Real World Data Methods

Education

MSc, Medical Statistics and Health Data Science, University of Bristol
Post-doctoral Fellowship, The CHOICE Institute, UW and Roche Global Pharma Business
PhD, Health Services Research, UW
MBA, University of San Francisco
PharmD, University of the Pacific
Clinical Pharmacy Residency, Palo Alto VA Medical Center

Research Interests

Evidence synthesis; systematic reviews, meta-analysis, network meta-analysis using Bayesian and frequentist methods.
Precision medicine: pharmacogenomics; genomic risk for hereditary cancers.
Health technology assessment and outcomes research including preference-based methods, discrete choice experiments and multi-criteria decision analysis.
Comparative effectiveness research in the context of clinical informatics.
Real world evidence of costs and outcomes.
Medication safety.

Biography

Beth Devine is Professor Emerita at The CHOICE Institute, School of Pharmacy Prior to becoming emerita, she held adjunct professorships in the Department of Health-Systems and Population Health, School of Public Health and the Department of Biomedical Informatics, School of Medicine.

She also held the Shirley and Herb Bridge Endowed Professor for Women in Pharmacy (2021-2023). She is currently a Visiting Professor at the University of Bristol, UK (2024-2026). She was a Fulbright US Scholar to the University of Murcia, Spain (2021-2022) and an Honorary Professor there (2022-2023).

She is currently president-elect of ISPOR – The Professional Society for Health Economics and Outcomes Research (2025-2026), was a member of the Board of Directors of ISPOR (2021-2024) and is an Associate Editor for the ISPOR journal Value in Health (2021-2029). She served on the ISPOR Task Force that developed guidelines to conduct network meta-analyses (2009-2011) and is currently co-chairing the ISPOR Task Force to update to these guidelines (2026). From 2014-2025 she served as an Assistant Director of the AHRQ-funded Pacific Northwest Evidence-based Practice Center. In 2013, she was elected as a member of the Society for Research Synthesis Methodology.

Prior to joining the faculty at the UW, Dr. Devine was an advanced practice (prescribing) clinical pharmacist and led the Pharmacy & Therapeutics Committee at the University of California San Francisco. where she served a term as president of the California Society of Health-System Pharmacists, earning their Lifetime Achievement Award for her leadership role in advancing the scope of practice for California pharmacists through legislation (1994).

Courses Taught

HEOR DS 510: Data Science in Health Economics and Outcomes Research
HECON 530 – Health Technology Assessment in a Global Environment
HEOR 531/HSERV 584 – Assessing Outcomes in Health & Medicine
PHRMCY 514 – Design and Analysis of Medical Studies

Selected Peer-Reviewed Publications

MyNCBI Bibliography
https://www.ncbi.nlm.nih.gov/myncbi/emily.devine.1/bibliography/public/

Google Scholar Profile: (n = 336; citations: 11294; h-index = 43, i10-index = 128)
https://scholar.google.com/citations?user=Wor4Qv0AAAAJ&hl=en